Endoscopy 2014; 46(02): 98-104
DOI: 10.1055/s-0033-1344986
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Narrow band imaging does not reliably predict residual intestinal metaplasia after radiofrequency ablation at the neo-squamo columnar junction

Lorenza Alvarez Herrero
1   Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, The Netherlands
2   Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
,
Wouter L. Curvers
2   Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
,
Raf Bisschops
3   Department of Gastroenterology and Hepatology, University Hospital Leuven, Leuven, Belgium
,
Mohammed A. Kara
2   Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
,
Erik J. Schoon
4   Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, The Netherlands
,
Fiebo J. W. ten Kate
5   Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands
,
Mike Visser
5   Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands
,
Bas L. A. M. Weusten
1   Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, The Netherlands
2   Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
,
Jacques J. G. H. M. Bergman
2   Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

submitted 06 November 2012

accepted after revision 18 September 2013

Publication Date:
29 January 2014 (online)

Background and study aims: After radiofrequency ablation (RFA) of Barrett’s esophagus, it may be difficult to determine whether complete eradication of intestinal metaplasia at the neosquamocolumnar junction (neo-SCJ) in the cardia has been achieved. It is claimed that narrow band imaging (NBI) may predict the presence of intestinal metaplasia, which would enable immediate treatment. The aim of the current study was to evaluate whether inspection of the neo-SCJ with NBI after RFA results in reliable detection of intestinal metaplasia.

Patients and methods: Patients with a normal-appearing neo-SCJ who were scheduled for RFA were included in the study. Two expert endoscopists obtained images from the neo-SCJ in overview (high resolution white light and NBI mode) and from four areas using NBI zoom, followed by corresponding biopsies. Four other blinded expert endoscopists evaluated the images for the presence of intestinal metaplasia and type of mucosal pattern (round, small tubular, large tubular, villous). Endpoints were sensitivity and specificity for identifying patients and areas with intestinal metaplasia.

Results: From 21 patients overview images from 21 neo-SCJs and NBI zoom images from 83 neo-SCJ areas were obtained. Intestinal metaplasia was present in five overview images (24 %) and nine zoom images (11 %). Using the overview images, sensitivity and specificity for identifying patients with intestinal metaplasia were 65 % (95 % confidence interval [CI] 38 – 86) and 46 % (95 %CI 33 – 60), respectively. For individual zoom images, sensitivity was 71 % (95 %CI 54 – 85) and specificity was 37 % (95 %CI 32 – 43).

Conclusions: After RFA, endoscopic inspection of the neo-SCJ with NBI in overview or zoom does not reliably predict presence or absence of intestinal metaplasia.

 
  • References

  • 1 Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 2008; 103: 788-797
  • 2 Hameeteman W, Tytgat GN, Houthoff HJ et al. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-1256
  • 3 Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008; 68: 867-876
  • 4 Gondrie JJ, Pouw RE, Sondermeijer CM et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008; 40: 370-379
  • 5 Gondrie JJ, Pouw RE, Sondermeijer CM et al. Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008; 40: 359-369
  • 6 Pouw RE, Gondrie JJ, Sondermeijer CM et al. Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg 2008; 12: 1627-1636
  • 7 Pouw RE, Wirths K, Eisendrath P et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 2009; 8: 23-29
  • 8 Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
  • 9 Bergman JJ. Radiofrequency ablation – great for some or justified for many?. N Engl J Med 2009; 360: 2353-2355
  • 10 Van Vilsteren FG, Pouw RE, Seewald S et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011; 60: 765-773
  • 11 Herrero LA, Van Vilsteren FG, Pouw RE et al. Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett’s esophagus longer than 10 cm. Gastrointest Endosc 2011; 73: 682-690
  • 12 Hamamoto Y, Endo T, Nosho K et al. Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett’s esophagus. J Gastroenterol 2004; 39: 14-20
  • 13 Sharma P, Bansal A, Mathur S et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett’s esophagus. Gastrointest Endosc 2006; 64: 167-175
  • 14 Goda K, Tajiri H, Ikegami M et al. Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett’s adenocarcinoma. Gastrointest Endosc 2007; 65: 36-46
  • 15 Anagnostopoulos GK, Yao K, Kaye P et al. Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging. Aliment Pharmacol Ther 2007; 26: 501-507
  • 16 Curvers WL, van den Broek FJ, Reitsma JB et al. Systematic review of narrow-band imaging for the detection and differentiation of abnormalities in the esophagus and stomach (with video). Gastrointest Endosc 2009; 69: 307-317
  • 17 Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-1399
  • 18 Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000
  • 19 Endo T, Awakawa T, Takahashi H et al. Classification of Barrett’s epithelium by magnifying endoscopy. Gastrointest Endosc 2002; 55: 641-647
  • 20 Guelrud M, Herrera I, Essenfeld H et al. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett’s esophagus. Gastrointest Endosc 2001; 53: 559-565
  • 21 Gardner MJ. Confidence interval analysis. London: British Medical Journal; 1989
  • 22 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174
  • 23 Norimura D, Isomoto H, Nakayama T et al. Magnifying endoscopic observation with narrow band imaging for specialized intestinal metaplasia in Barrett’s esophagus with special reference to light blue crests. Dig Endosc 2010; 22: 101-106
  • 24 Kiesslich R, Gossner L, Goetz M et al. In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol 2006; 4: 979-987